A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 96 (1), 198-203
- https://doi.org/10.1016/j.ygyno.2004.09.022
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2001
- Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapyBritish Journal of Cancer, 1997
- A Phase I Study of Weekly Cisplatin and Whole Abdominal Radiation for the Treatment of Stage III and IV Endometrial Carcinoma: A Gynecologic Oncology Group Pilot StudyGynecologic Oncology, 1996
- A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Treatment of Advanced or Recurrent Endometrial Carcinoma with Single-Agent CarboplatinGynecologic Oncology, 1993
- Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma A Gynecologic Oncology Group studyAmerican Journal of Clinical Oncology, 1984